coronary artery diffuse disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) a clear definition of coronary artery disease 2) studies for diffuse coronary artery-diseased patients who were treated with percutaneous coronary intervention or cardiac surgery 3) Hazard rate of 1-year survival or 1-year mortality, 5-year survival rate or 5-year mortality, MACCE
Exclusion criteria
Exclusion criteria: 1) non-English articles, series of < 10 patients, case reports, animal studies, abstracts, editorials, commentaries, systematic reviews, and narrative reviews 2) pediatric, infection, drug treatment, cell treatment, other artery diseases, chronic total occlusion (CTO), graft disease, in-stent restenosis (ISR), diagnosis, treatment technique, bare metal stent (BMS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The hazard ratio for 1-year survival or 1-year mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| the hazard ratio for 5-year survival or 5-year mortality, retreatment rate, Myocardial infarction incidence, Stroke incidence, treatment success rate | — |
Countries
Japan
Contacts
Joint Graduate School of Tokyo Womens Medical University and Waseda University Cooperative Major in Advanced Biomedical Sciences